Method for treating Philadelphia-negative myeloproliferative syndromes

Method for treating Philadelphia-negative myeloproliferative syndromes in a patient in need of such treatment, by administering to the patient diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates...

Full description

Saved in:

Bibliographic Details
Main Authors	Mascagni, Paolo, D'urzo, Carmine, Golay, Joseê
Format	Patent
Language	English
Published	10.07.2012
Online Access	Get full text

Cover

Loading…

More Information
Summary:	Method for treating Philadelphia-negative myeloproliferative syndromes in a patient in need of such treatment, by administering to the patient diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphthalen-2-yl-methyl]-ammonium chloride or other pharmaceutically acceptable salts and/or solvates thereof, in combination with N-hydroxyurea.